Abbott Labs (ABT) Declares $0.22 Quarterly Dividend; 2.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Abbott Laboratories (ABT) Tops Q2 EPS by 3c; Boosts FY14 EPS Outlook
July 16, 2014 7:46 AM EDTAbbott Laboratories (NYSE: ABT) reported Q2 EPS of $0.54, $0.03 better than the analyst estimate of $0.51. Revenue for the quarter came in at $5.55 billion versus the consensus estimate of $5.53 billion.
Sales increased 1.9 percent on a reported basis, including an unfavorable 1.1 percent effect of foreign exchange.
International... More
